Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
RecruitingObservational study
Who can join
Ages 15 to 100 · Women
Full eligibility criteria
Inclusion Criteria: * Patient received IV Artesunate * Patient was pregnant while receiving IV Artesunate * Patient was at least 15 years of age * Patient or legal guardian/representative gave consent for the study and to collect data from her physicians Exclusion Criteria • None
About the study
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Sponsor: Amivas Inc. · Participants: 25 · Started: Jun 8, 2022
Contact the study team
- Katrina Riggs · Phone: 3017622609
Official record on ClinicalTrials.gov — NCT05285735
Locations in the U.S.
| New Jersey | 4C Pharma Solutions, Piscataway |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.